Concepedia

Hepatitis C: an economic evaluation of extended treatment with interferon

Alan Shiell, Sue Brown, Geoff Farrell

The Medical Journal of Australia · 1999 · 23 citations · 11 references

DOI

Abstract

The cost effectiveness of IF alpha treatment for HCV infection has improved as a result of better patient selection, cost reductions and enhanced effectiveness of extended treatment. The results are sensitive to assumptions made about quality of life and the discount rate.

References

11

Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients

Giovanna Fattovich, G. Giustina, Françoise Degos et al. · Gastroenterology · 1997 · 1.4K citations

, , +8

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

Graham R. Foster, Robert Goldin, Howard C. Thomas · Hepatology · 1998 · 563 citations

, , +17

Standardizing Methodologies for Economic Evaluation in Health Care: <i>Practice, Problems, and Potential</i>

Michael Drummond, Arno Brandt, Bryan R. Luce et al. · International Journal of Technology Assessment in Health Care · 1993 · 233 citations

, , +11

Cost-Effectiveness of 6 and 12 Months of Interferon-α Therapy for Chronic Hepatitis C

W. Ray Kim · Annals of Internal Medicine · 1997 · 151 citations

Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile.

Gary L. Davis, L A Balart, Eugene R. Schiff et al. · PubMed · 1994 · 150 citations